Product NDC: | 59572-420 |
Proprietary Name: | Revlimid |
Non Proprietary Name: | Lenalidomide |
Active Ingredient(s): | 20 mg/1 & nbsp; Lenalidomide |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 59572-420 |
Labeler Name: | Celgene Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021880 |
Marketing Category: | NDA |
Start Marketing Date: | 20130606 |
Package NDC: | 59572-420-00 |
Package Description: | 100 CAPSULE in 1 BOTTLE (59572-420-00) |
NDC Code | 59572-420-00 |
Proprietary Name | Revlimid |
Package Description | 100 CAPSULE in 1 BOTTLE (59572-420-00) |
Product NDC | 59572-420 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Lenalidomide |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20130606 |
Marketing Category Name | NDA |
Labeler Name | Celgene Corporation |
Substance Name | LENALIDOMIDE |
Strength Number | 20 |
Strength Unit | mg/1 |
Pharmaceutical Classes |